Thrive Launches With $110M Series A Financing To Integrate Earlier Detection Of Multiple Cancer Types Into Routine Medical Care

by vcaonline.com posted 1year ago 180 views

Thrive Launches with $110 Million Series A Financing to Integrate Earlier Detection of Multiple Cancer Types into Routine Medical Care

Company Advancing CancerSEEK, A DNA- and Protein-based Liquid Biopsy Test Developed by The Vogelstein Lab at Johns Hopkins University

10,000 Person Prospective Trial Fully Enrolled with Geisinger; Financing Will Support Expanded Clinical Development to Enable Regulatory Approvals and Broad Reimbursement Access

Company Will Integrate Real-World Data and Machine Learning to Enable a Comprehensive Care Solution for Primary Care Physicians

Third Rock Ventures Led Financing Together with Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, Invus, Exact Sciences ...

In this article